NORVIR
LOE ApproachingNDAORALCAPSULEPriority Review
Approved
Mar 1996
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
4/8 — Partial
Priority Review
NORVIR by Abbott is [see microbiology ( ) ] . Approved for combination with other antiretroviral agents for the treatment of pediatric patients with hiv-1 infection. First approved in 1996.
Drug data last refreshed 14h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
NORVIR (ritonavir) is a protease inhibitor oral capsule approved in 1996 for HIV-1 treatment in pediatric patients as part of combination antiretroviral therapy. It works by inhibiting HIV protease, preventing viral replication. The drug is a small-molecule antiviral indicated exclusively in combination with other antiretroviral agents.
LOE Approaching
Product approaching loss of exclusivity with minimal linked career opportunities; team size likely stable or contracted.
Mechanism of Action
[see Microbiology ( ) ] .
Clinical Trials (1)
Measure of Pharmacokinetic Parameters and Adherence With MEMS in Naive HIV Infected Patients Treated With Reyataz Once Daily Combined With Norvir and Truvada
Started Jan 2008
35 enrolled
HIV Infections
Career Relevance
NORVIR offers limited growth career opportunities given LOE-approaching status and zero linked job postings. Roles focus on regulatory defense, lifecycle management, and transition planning rather than expansion or innovation.
Worked on NORVIR at Abbott? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.